169 related articles for article (PubMed ID: 29377574)
61. Interferon monotherapy for patients with chronic hepatitis C and normal serum aminotransferase levels at commencement of treatment.
Mamori S; Suzuki F; Hosaka T; Akuta N; Someya T; Kobayashi M; Tsubota A; Suzuki Y; Saitoh S; Arase Y; Ikeda K; Kumada H
J Gastroenterol; 2004 Aug; 39(8):776-82. PubMed ID: 15338372
[TBL] [Abstract][Full Text] [Related]
62. Elevation of Serum Aminotransferase Levels and Future Risk of Death from External Causes: A Prospective Cohort Study in Korea.
Sohn J; Kang DR; Kim HC; Cho J; Choi YJ; Kim C; Suh I
Yonsei Med J; 2015 Nov; 56(6):1582-9. PubMed ID: 26446640
[TBL] [Abstract][Full Text] [Related]
63. Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage.
Wu IC; Lai CL; Han SH; Han KH; Gordon SC; Chao YC; Tan CK; Sievert W; Tanwandee T; Xu D; Neo BL; Chang TT
Hepatology; 2010 Apr; 51(4):1185-9. PubMed ID: 20044806
[TBL] [Abstract][Full Text] [Related]
64. Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels.
Tseng TC; Liu CJ; Wang CC; Chen PJ; Lai MY; Chen DS; Kao JH
Antivir Ther; 2009; 14(2):203-10. PubMed ID: 19430095
[TBL] [Abstract][Full Text] [Related]
65. [Characteristic of liver pathology in HBeAg-positive and HBeAg-negative chronic hepatitis B patients with mildly elevated ALT].
Liu SQ; Zhu XJ; Sun XH; Li M; Gao YQ
Zhonghua Gan Zang Bing Za Zhi; 2012 May; 20(5):348-52. PubMed ID: 22971279
[TBL] [Abstract][Full Text] [Related]
66. Risk of mortality and level of serum alanine aminotransferase among community-dwelling elderly in Israel.
Schmilovitz-Weiss H; Gingold-Belfer R; Boltin D; Beloosesky Y; Meyerovitch J; Tor R; Issa N; Grossman A; Koren-Morag N; Weiss A
Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1428-1433. PubMed ID: 30048334
[TBL] [Abstract][Full Text] [Related]
67. Updated thresholds for serum alanine aminotransferase level in a large-scale population study composed of 34 346 subjects.
Wu WC; Wu CY; Wang YJ; Hung HH; Yang HI; Kao WY; Su CW; Wu JC; Chan WL; Lin HC; Lee FY; Lee SD
Aliment Pharmacol Ther; 2012 Sep; 36(6):560-8. PubMed ID: 22817613
[TBL] [Abstract][Full Text] [Related]
68. Histologic changes in liver tissue from patients with chronic hepatitis B and minimal increases in levels of alanine aminotransferase: a meta-analysis and systematic review.
Nguyen LH; Chao D; Lim JK; Ayoub W; Nguyen MH
Clin Gastroenterol Hepatol; 2014 Aug; 12(8):1262-6. PubMed ID: 24361419
[TBL] [Abstract][Full Text] [Related]
69. Natural History of Chronic Hepatitis B Virus Infection in Ahvaz City, Iran.
Makvandi M; Soleimani Jelodar R; Samarbafzadeh A; Neisi N; Sharifi Z; Gholampour A; Masjedizadeh A; Shayesteh A
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2125-2129. PubMed ID: 30139211
[TBL] [Abstract][Full Text] [Related]
70. Nucleos(t)ide Analogue Treatment for Patients With Hepatitis B Virus (HBV) e Antigen-Positive Chronic HBV Genotype C Infection: A Nationwide, Multicenter, Retrospective Study.
Chang Y; Choe WH; Sinn DH; Lee JH; Ahn SH; Lee H; Shim JJ; Jun DW; Park SY; Nam JY; Cho EJ; Yu SJ; Lee DH; Lee JM; Kim YJ; Kwon SY; Paik SW; Yoon JH
J Infect Dis; 2017 Dec; 216(11):1407-1414. PubMed ID: 29029102
[TBL] [Abstract][Full Text] [Related]
71. High serum resistin associates with intrahepatic inflammation and necrosis: an index of disease severity for patients with chronic HBV infection.
Meng Z; Zhang Y; Wei Z; Liu P; Kang J; Zhang Y; Ma D; Ke C; Chen Y; Luo J; Gong Z
BMC Gastroenterol; 2017 Jan; 17(1):6. PubMed ID: 28061755
[TBL] [Abstract][Full Text] [Related]
72. Off-treatment efficacy of 3-year nucleos(t)ide analogues in chronic hepatitis B patients.
Lin CC; Bair MJ; Chen CJ; Lee KH; Chen MJ; Liu CY; Chang CW; Hu KC; Liou TC; Lin SC; Wang HY; Chu CH; Shih SC; Wang TE
Kaohsiung J Med Sci; 2016 Jan; 32(1):10-5. PubMed ID: 26853169
[TBL] [Abstract][Full Text] [Related]
73. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.
Lee MH; Yang HI; Liu J; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; You SL; Wang LY; Chen CJ;
Hepatology; 2013 Aug; 58(2):546-54. PubMed ID: 23504622
[TBL] [Abstract][Full Text] [Related]
74. Retrospective evaluation of serum markers APRI and AST/ALT for assessing liver fibrosis and cirrhosis in chronic hepatitis B and C patients with hepatocellular carcinoma.
Lin CS; Chang CS; Yang SS; Yeh HZ; Lin CW
Intern Med; 2008; 47(7):569-75. PubMed ID: 18379139
[TBL] [Abstract][Full Text] [Related]
75. Histological improvement of long-term antiviral therapy in chronic hepatitis B patients with persistently normal alanine aminotransferase levels.
Du X; Wang J; Shao L; Hu X; Yang C; Shen L; Weng X; Zhang W
J Viral Hepat; 2013 May; 20(5):328-35. PubMed ID: 23565615
[TBL] [Abstract][Full Text] [Related]
76. [Association of liver histopathology and clinical features among patients with chronic hepatitis B virus infection].
Lu CT; Gao GS
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Jun; 25(3):214-6. PubMed ID: 21977596
[TBL] [Abstract][Full Text] [Related]
77. Rates of Treatment Eligibility in Follow-Up of Patients with Chronic Hepatitis B (CHB) Across Various Clinical Settings Who Were Initially Ineligible at Presentation.
Uribe LA; Nguyen N; Kim L; Trinh HN; Wong C; Wong C; Nguyen LH; Nguyen MH
Dig Dis Sci; 2016 Feb; 61(2):618-25. PubMed ID: 26660679
[TBL] [Abstract][Full Text] [Related]
78. Clinical significance of hepatitis B virus precore and core promoter variants in Korean patients with chronic hepatitis B.
Yim SY; Um SH; Young Jung J; Kim TH; Kim JD; Keum B; Seo YS; Yim HJ; Jeen YT; Lee HS; Chun HJ; Kim CD; Ryu HS
J Clin Gastroenterol; 2015 Jan; 49(1):61-8. PubMed ID: 24406435
[TBL] [Abstract][Full Text] [Related]
79. Upper normal threshold of serum alanine aminotransferase in identifying individuals at risk for chronic liver disease.
Park HN; Sinn DH; Gwak GY; Kim JE; Rhee SY; Eo SJ; Kim YJ; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
Liver Int; 2012 Jul; 32(6):937-44. PubMed ID: 22260521
[TBL] [Abstract][Full Text] [Related]
80. Upper limits of normal for alanine aminotransferase activity in the United States population.
Ruhl CE; Everhart JE
Hepatology; 2012 Feb; 55(2):447-54. PubMed ID: 21987480
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
